PhRMA To Follow Through With Campaign Despite Abated Threat Of Price Controls

The Pharmaceutical Research and Manufacturers of America will follow through with its campaign against the negative coverage of drug prices, a PhRMA spokesman said, despite what most lobbyists and analysts consider a much lower threat of drug price controls following Republican victories at the polls a month ago. “Yes, it's still on,” PhRMA Executive Vice President of Public Affairs Robert Zirkelbach said of the campaign. Politico reported in October that PhRMA was hiking membership dues 50 percent to raise...